{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T14:16:56Z","timestamp":1789827416943,"version":"4.0.1"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","award":["1073490"],"award-info":[{"award-number":["1073490"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"St Vincent's Clinic Foundation"},{"DOI":"10.13039\/501100000942","name":"Brain Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000942","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.neuropharm.2017.04.045","type":"journal-article","created":{"date-parts":[[2017,5,3]],"date-time":"2017-05-03T03:16:31Z","timestamp":1493781391000},"page":"98-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["In\u00a0vivo assessment of neurological channelopathies: Application of peripheral nerve excitability studies"],"prefix":"10.1016","volume":"132","author":[{"given":"Susan E.","family":"Tomlinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Howells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2017.04.045_bib1","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1113\/jphysiol.2008.155077","article-title":"Vesicular apparatus, including functional calcium channels, are present in developing rodent optic nerve axons and are required for normal node of Ranvier formation","volume":"586","author":"Alix","year":"2008","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1023\/A:1007009613484","article-title":"Myelinating schwann cells determine the internodal localization of Kv1.1, Kv1.2, Kvbeta2, and caspr","volume":"28","author":"Arroyo","year":"1999","journal-title":"J.\u00a0Neurocytol."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1113\/jphysiol.1987.sp016395","article-title":"Function and distribution of three types of rectifying channel in rat spinal root myelinated axons","volume":"383","author":"Baker","year":"1987","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1113\/jphysiol.1982.sp014064","article-title":"Intracellular recording from vertebrate myelinated axons: mechanism of the depolarizing afterpotential","volume":"323","author":"Barrett","year":"1982","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1126\/science.279.5349.403","article-title":"A\u00a0potassium channel mutation in neonatal human epilepsy","volume":"279","author":"Biervert","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2017.04.045_bib6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1113\/jphysiol.1983.sp014792","article-title":"The strength-duration relationship for excitation of myelinated nerve: computed dependence on membrane parameters","volume":"341","author":"Bostock","year":"1983","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib7","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/0006-8993(88)90564-1","article-title":"Evidence for two types of potassium channel in human motor axons in\u00a0vivo","volume":"462","author":"Bostock","year":"1988","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1113\/jphysiol.1997.sp021857","article-title":"Latent addition in motor and sensory fibres of human peripheral nerve","volume":"498","author":"Bostock","year":"1997","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/(SICI)1097-4598(199802)21:2<137::AID-MUS1>3.0.CO;2-C","article-title":"Threshold tracking techniques in the study of human peripheral nerve","volume":"21","author":"Bostock","year":"1998","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neuropharm.2017.04.045_bib10","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ng1094-136","article-title":"Episodic ataxia\/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1","volume":"8","author":"Browne","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib11","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/brain\/113.5.1361","article-title":"Familial paroxysmal kinesigenic ataxia and continuous myokymia","volume":"113","author":"Brunt","year":"1990","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2017.04.045_bib12","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S1388-2457(01)00595-8","article-title":"Excitability of human axons","volume":"112","author":"Burke","year":"2001","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0896-6273(00)81133-2","article-title":"From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels","volume":"1","author":"Catterall","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2017.04.045_bib14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/ng0198-53","article-title":"A\u00a0pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family","volume":"18","author":"Charlier","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib15","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pain.2007.07.026","article-title":"Pain. The roles of sodium channels in nociception: implications for mechanisms of pain","volume":"131","author":"Cummins","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2017.04.045_bib16","doi-asserted-by":"crossref","first-page":"6226","DOI":"10.1523\/JNEUROSCI.17-16-06226.1997","article-title":"Differential localization of voltage dependent calcium channel alpha1 subunits at the human and rat neuromuscular junction","volume":"17","author":"Day","year":"1997","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib17","doi-asserted-by":"crossref","first-page":"12272","DOI":"10.1073\/pnas.211431298","article-title":"Myokymia and neonatal epilepsy caused by a mutation in the voltage sensor of the KCNQ2 K+ channel","volume":"98","author":"Dedek","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0920-1211(03)00037-8","article-title":"Neonatal convulsions and epileptic encephalopathy in an Italian family with a missense mutation in the fifth transmembrane region of KCNQ2","volume":"54","author":"Dedek","year":"2003","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib19","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/WNP.0b013e318257c0a0","article-title":"Effects of topiramate on peripheral nerve excitability","volume":"29","author":"Erdo\u011fan","year":"2012","journal-title":"J.\u00a0Clin. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib20","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1111\/j.1528-1167.2010.02640.x","article-title":"Sodium channel SCN1A and epilepsy: mutations and mechanisms","volume":"51","author":"Escayg","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2017.04.045_bib21","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/1531-8249(200010)48:4<647::AID-ANA12>3.0.CO;2-Q","article-title":"Clinical, genetic, and expression studies of mutations in the potassium channel gene KCNA1 reveal new phenotypic variability","volume":"48","author":"Eunson","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jneumeth.2016.09.009","article-title":"Assessment of axonal excitability properties in two branches of the human facial nerve","volume":"274","author":"Eviston","year":"2016","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2017.04.045_bib23","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1113\/jphysiol.2012.240820","article-title":"Evolution of peripheral nerve function in humans: novel insights from motor nerve excitability","volume":"591","author":"Farrar","year":"2013","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib24","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/ana.20241","article-title":"Electromyography guides toward subgroups of mutations in muscle channelopathies","volume":"56","author":"Fournier","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib25","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/mds.870010404","article-title":"Autosomal dominant episodic ataxia: a heterogeneous syndrome","volume":"1","author":"Gancher","year":"1986","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib26","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nrneurol.2016.140","article-title":"Pathophysiological and diagnostic implications of cortical dysfunction in ALS","volume":"12","author":"Geevasinga","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib85","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/brain\/awh020","article-title":"Nerve excitability properties in Charcot-Marie-Tooth disease type 1A","volume":"127","author":"Hattori","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2017.04.045_bib27","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/jmg.2007.051938","article-title":"Deletions or duplications in KCNQ2 can cause benign familial neonatal seizures","volume":"44","author":"Heron","year":"2007","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib28","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1113\/jphysiol.2011.225573","article-title":"The voltage dependence of Ih in human myelinated axons","volume":"590","author":"Howells","year":"2012","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib29","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1113\/jphysiol.2012.249060","article-title":"Excitability and the safety margin in human axons during hyperthermia","volume":"591","author":"Howells","year":"2013","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib30","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1113\/jphysiol.2006.123661","article-title":"Plasticity of inwardly rectifying conductances following a corticospinal lesion in human subjects","volume":"581","author":"Jankelowitz","year":"2007","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib31","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1212\/WNL.53.1.34","article-title":"A\u00a0novel nonsense mutation in CACNA1A causes episodic ataxia and hemiplegia","volume":"53","author":"Jen","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2017.04.045_bib32","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1212\/WNL.57.10.1843","article-title":"Loss-of-function EA2 mutations are associated with impaired neuromuscular transmission","volume":"57","author":"Jen","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2017.04.045_bib33","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1093\/brain\/awm126","article-title":"The CINCH investigators. Primary episodic ataxias: diagnosis, pathogenesis and treatment","volume":"130","author":"Jen","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2017.04.045_bib34","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/brain\/awg073","article-title":"Muscle cramp in Machado-Joseph disease: altered motor axonal excitability properties and mexiletine treatment","volume":"126","author":"Kanai","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2017.04.045_bib35","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/(SICI)1097-4598(200003)23:3<399::AID-MUS12>3.0.CO;2-G","article-title":"Multiple measures of axonal excitability: a new approach in clinical testing","volume":"23","author":"Kiernan","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neuropharm.2017.04.045_bib36","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1093\/brain\/123.12.2542","article-title":"Effects of membrane polarization and ischaemia on the excitability properties of human motor axons","volume":"123","author":"Kiernan","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2017.04.045_bib37","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/brain\/124.4.816","article-title":"Effects of temperature on the excitability properties of human motor axons","volume":"124","author":"Kiernan","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2017.04.045_bib38","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/ana.20395","article-title":"Acute tetrodotoxin-induced neurotoxicity after ingestion of puffer fish","volume":"57","author":"Kiernan","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib39","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1093\/brain\/awh520","article-title":"Mutation in the Na+ channel subunit SCN1B produces paradoxical changes in peripheral nerve excitability","volume":"128","author":"Kiernan","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2017.04.045_bib40","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.nmd.2004.06.007","article-title":"Expanding the phenotype of potassium channelopathy: severe neuromyotonia and skeletal deformities without prominent episodic ataxia","volume":"14","author":"Kinali","year":"2004","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib41","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1098\/rspb.1982.0095","article-title":"Regenerating mammalian nerve fibres: changes in action potential waveform and firing characteristics following blockage of potassium conductance","volume":"217","author":"Kocsis","year":"1982","journal-title":"Proc. R. Soc. Lond B Biol. Sci."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1529-8027.2008.00155.x","article-title":"Assessment of nerve excitability in toxic and metabolic neuropathies","volume":"13","author":"Krishnan","year":"2008","journal-title":"J.\u00a0Peripher Nerv. Syst."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib43","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.pneurobio.2009.08.002","article-title":"Axonal ion channels from bench to bedside: a translational neuroscience perspective","volume":"89","author":"Krishnan","year":"2009","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib44","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/mus.25274","article-title":"Association between glycemic variability and peripheral nerve dysfunction in type 1 diabetes","volume":"54","author":"Kwai","year":"2016","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neuropharm.2017.04.045_bib45","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/archneurol.2011.137","article-title":"Modulatory effects on axonal function after intravenous immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy","volume":"68","author":"Lin","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib46","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1113\/jphysiol.2008.150656","article-title":"Nervous system KV7 disorders: breakdown of a subthreshold brake","volume":"586","author":"Maljevic","year":"2008","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib47","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/mus.880090805","article-title":"The exercise test in periodic paralysis","volume":"9","author":"McManis","year":"1986","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.1016\/j.neuropharm.2017.04.045_bib48","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S1474-4422(15)00014-9","article-title":"Sensitivity and specificity of threshold tracking transcranial magnetic stimulation for diagnosis of amyotrophic lateral sclerosis: a prospective study","volume":"14","author":"Menon","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib49","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/brain\/119.2.439","article-title":"Strength-duration properties of human peripheral nerve","volume":"119","author":"Mogyoros","year":"1996","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2017.04.045_bib50","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1113\/jphysiol.2004.069476","article-title":"Persistent abnormalities of membrane excitability in regenerated mature motor axons in cat","volume":"560","author":"Moldovan","year":"2004","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib51","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/brain\/awn332","article-title":"Motor axon excitability during Wallerian degeneration","volume":"132","author":"Moldovan","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2017.04.045_bib52","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1016\/j.clinph.2011.04.007","article-title":"A\u00a0comparison of the excitability of motor axons innervating the APB and ADM muscles","volume":"122","author":"Murray","year":"2011","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib53","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13073-015-0214-7","article-title":"Advancing epilepsy genetics in the genomic era","volume":"7","author":"Myers","year":"2015","journal-title":"Genome Med."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib54","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/brain\/awh020","article-title":"Nerve excitability properties in Charcot-Marie-Tooth disease type 1A","volume":"127","author":"Nodera","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2017.04.045_bib55","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.clinph.2006.01.018","article-title":"Nerve excitability testing and its clinical application to neuromuscular diseases","volume":"117","author":"Nodera","year":"2006","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib56","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1111\/j.1528-1167.2012.03631.x","article-title":"Sodium channels and the neurobiology of epilepsy","volume":"53","author":"Oliva","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2017.04.045_bib57","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0092-8674(00)81373-2","article-title":"Familial hemiplegic migraine and episodic ataxia type 2 are caused by mutations in the Ca2+ channel gene. CACNL1A4","volume":"87","author":"Ophoff","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2017.04.045_bib58","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1093\/brain\/awp219","article-title":"Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy","volume":"132","author":"Park","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2017.04.045_bib59","series-title":"The Circuitry of the Human Spinal Cord. Its Role in Motor Control and Movement Disorders","author":"Pierrot-Deseilligny","year":"2005"},{"key":"10.1016\/j.neuropharm.2017.04.045_bib60","series-title":"Epileptic Syndromes in Infancy, Childhood and Adolescence","first-page":"3","article-title":"Benign familial and non-familial neonatal seizures","author":"Plouin","year":"2005"},{"key":"10.1016\/j.neuropharm.2017.04.045_bib61","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.nurt.2007.01.010","article-title":"Episodic ataxia type 1: a neuronal potassium channelopathy","volume":"4","author":"Rajakulendran","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuropharm.2017.04.045_bib88","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1113\/jphysiol.2009.186437","article-title":"Genetic and functional characterisation of the P\/Q calcium channel in episodic ataxia with epilepsy","volume":"588","author":"Rajakulendran","year":"2010","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib62","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.pneurobio.2008.09.016","article-title":"Mechanisms of human inherited epilepsies","volume":"87","author":"Reid","year":"2009","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib63","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/brain\/120.3.479","article-title":"Generalized epilepsy with febrile seizures plus. A genetic disorder with heterogeneous clinical phenotypes","volume":"120","author":"Scheffer","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2017.04.045_bib87","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.braindev.2009.01.001","article-title":"Dravet syndrome or genetic (generalized) epilepsy with febrile seizures plus?","volume":"31","author":"Scheffer","year":"2009","journal-title":"Brain Dev."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib64","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/BF00374660","article-title":"Action potentials and membrane currents in the human node of ranvier","volume":"430","author":"Schwarz","year":"1995","journal-title":"Pfl\u00fcgers Arch."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib86","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1113\/jphysiol.2006.106815","article-title":"KCNQ channels mediate IKs, a slow K+ current regulating excitability in the rat node of Ranvier","volume":"573","author":"Schwarz","year":"2006","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib65","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng0198-25","article-title":"A\u00a0novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns","volume":"18","author":"Singh","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib66","first-page":"37","article-title":"Genetic neurological channelopathies: molecular genetics and clinical phenotypes","volume":"87","author":"Spillane","year":"2016","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.04.045_bib67","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/ana.22238","article-title":"Refined exercise testing can aid DNA-based diagnosis in muscle channelopathies","volume":"69","author":"Tan","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib68","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/mus.23293","article-title":"Membrane dysfunction in Andersen-Tawil syndrome assessed by velocity recovery cycles","volume":"46","author":"Tan","year":"2012","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neuropharm.2017.04.045_bib69","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/mus.24069","article-title":"Chloride channels in myotonia congenita assessed by velocity recovery cycles","volume":"49","author":"Tan","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neuropharm.2017.04.045_bib70","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/j.clinph.2009.07.003","article-title":"Clinical neurophysiology of the episodic ataxias: insights into ion channel dysfunction in\u00a0vivo","volume":"120","author":"Tomlinson","year":"2009","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib71","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/mus.21482","article-title":"In\u00a0vivo assessment of HCN channel current (Ih) in human motor axons","volume":"41","author":"Tomlinson","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neuropharm.2017.04.045_bib72","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1093\/brain\/awq318","article-title":"Nerve excitability studies characterize Kv1.1 fast potassium channel dysfunction in patients with episodic ataxia type 1","volume":"133","author":"Tomlinson","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2017.04.045_bib73","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1136\/jnnp-2012-304131","article-title":"Clinical, genetic, neurophysiological and functional study of new mutations in episodic ataxia type 1","volume":"84","author":"Tomlinson","year":"2013","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.04.045_bib74","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1093\/brain\/aws241","article-title":"In\u00a0vivo loss of slow potassium channel activity in individuals with benign familial neonatal epilepsy in remission","volume":"135","author":"Tomlinson","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2017.04.045_bib75","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/brain\/awv380","article-title":"In\u00a0vivo impact of presynaptic calcium channel dysfunction on motor axons in episodic ataxia type 2","volume":"139","author":"Tomlinson","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2017.04.045_bib76","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1113\/jphysiol.2006.126003","article-title":"Outwardly rectifying deflections in threshold electrotonus due to K+ conductances","volume":"580","author":"Trevillion","year":"2007","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib77","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1152\/physrev.00002.2008","article-title":"Localization and targeting of voltage-dependent ion channels in mammalian central neurons","volume":"88","author":"Vacher","year":"2008","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib78","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/mus.20481","article-title":"Assessment of cortical excitability using threshold tracking techniques","volume":"33","author":"Vucic","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neuropharm.2017.04.045_bib79","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/1252","article-title":"Febrile seizures and generalized epilepsy associated with a mutation in the Na\u00a0+ channel \u03b21 subunit gene SCN1B","volume":"19","author":"Wallace","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib80","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1212\/WNL.58.9.1426","article-title":"Generalized epilepsy with febrile seizures plus: mutation of the sodium channel subunit SCN1B","volume":"58","author":"Wallace","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2017.04.045_bib82","first-page":"413","article-title":"Sur la possibilit\u00e9 de rendre comparables entre eux les appareils servant \u00e0 l'excitation \u00e9lectrique","volume":"35","author":"Weiss","year":"1901","journal-title":"Arch. Ital. Biol."},{"key":"10.1016\/j.neuropharm.2017.04.045_bib83","first-page":"17","article-title":"The effects of valproic acid and carbamazepine on strength-duration properties of peripheral nerve","volume":"19","author":"Yerdelen","year":"2014","journal-title":"Neurosci. (Riyadh)"},{"key":"10.1016\/j.neuropharm.2017.04.045_bib84","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/brain\/122.5.817","article-title":"A\u00a0novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy","volume":"122","author":"Zuberi","year":"1999","journal-title":"Brain"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817301958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817301958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T20:22:59Z","timestamp":1602015779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390817301958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":87,"alternative-id":["S0028390817301958"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.04.045","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In\u00a0vivo assessment of neurological channelopathies: Application of peripheral nerve excitability studies","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.04.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}